These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


675 related items for PubMed ID: 8294874

  • 1. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.
    Glas R, Ohlén C, Höglund P, Kärre K.
    J Exp Med; 1994 Feb 01; 179(2):661-72. PubMed ID: 8294874
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Allospecific cytotoxic T cells generated from beta 2m-/- mice in primary MLC: analysis of activation requirements, specificity, and phenotype.
    Lamousé-Smith E, McCarthy SA.
    Cell Immunol; 1997 Aug 01; 179(2):107-15. PubMed ID: 9268494
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U, Schoel B, Kaufmann SH.
    J Immunol; 1994 Nov 01; 153(9):4070-80. PubMed ID: 7523514
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C, Höglund P, Sentman CL, Carbone E, Ljunggren HG, Koller B, Kärre K.
    Eur J Immunol; 1995 May 01; 25(5):1286-91. PubMed ID: 7774631
    [Abstract] [Full Text] [Related]

  • 10. MHC class I phenotype and function of human beta 2-microglobulin transgenic murine lymphocytes.
    Bjerager L, Pedersen LO, Bregenholt S, Nissen MH, Claesson MH.
    Scand J Immunol; 1996 Dec 01; 44(6):615-22. PubMed ID: 8972744
    [Abstract] [Full Text] [Related]

  • 11. Induction of peptide-specific CD8+ CTL clones in beta 2-microglobulin-deficient mice.
    Cook JR, Solheim JC, Connolly JM, Hansen TH.
    J Immunol; 1995 Jan 01; 154(1):47-57. PubMed ID: 7995959
    [Abstract] [Full Text] [Related]

  • 12. Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejection.
    Lamousé-Smith E, Clements VK, Ostrand-Rosenberg S.
    J Immunol; 1993 Dec 01; 151(11):6283-90. PubMed ID: 8245467
    [Abstract] [Full Text] [Related]

  • 13. CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class I expression.
    Udaka K, Marusić-Galesić S, Walden P.
    J Immunol; 1994 Sep 15; 153(6):2843-50. PubMed ID: 7915743
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alpha beta TCR+ cells are a minimal fraction of peripheral CD8+ pool in MHC class I-deficient mice.
    Nesić D, Santori FR, Vukmanović S.
    J Immunol; 2000 Aug 15; 165(4):1896-901. PubMed ID: 10925270
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Control of thymus-independent intestinal intraepithelial lymphocytes by beta 2-microglobulin.
    Neuhaus O, Emoto M, Blum C, Yamamoto S, Kaufmann SH.
    Eur J Immunol; 1995 Aug 15; 25(8):2332-9. PubMed ID: 7664795
    [Abstract] [Full Text] [Related]

  • 18. MHC class II molecules bind indiscriminately self and non-self peptide homologs: effect on the immunogenicity of non-self peptides.
    Sette A, Sidney J, Gaeta FC, Appella E, Colón SM, del Guercio MF, Guéry JC, Adorini L.
    Int Immunol; 1993 Jun 15; 5(6):631-8. PubMed ID: 8347557
    [Abstract] [Full Text] [Related]

  • 19. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V, Schild HJ, Gückel B, von Hoegen P.
    Immunol Cell Biol; 1993 Aug 15; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [Abstract] [Full Text] [Related]

  • 20. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
    Uger RA, Barber BH.
    J Immunol; 1998 Feb 15; 160(4):1598-605. PubMed ID: 9469415
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.